| 0.8496 Data as of 3:59pm ET |  -0.0645 / -7.06%Today’s Change | 0.37 Today|||52-Week Range 2.27 | +95.31% Year-to-Date |
| Merck KGaA Posts Higher Y/Y Earnings - Analyst Blog May 15 / Zacks.com | Salix Beats on Earnings - Analyst Blog May 14 / Zacks.com |
| Dr. Reddy's Earnings Increase Y/Y - Analyst Blog May 15 / Zacks.com | Narrower-than-Expected Loss at Supernus - Analyst Blog May 14 / Zacks.com |
| FDA Accepts Merck BLA - Analyst Blog May 15 / Zacks.com | Glaxo/THRX's Breo Ellipta Gets FDA Nod - Analyst Blog May 13 / Zacks.com |
| Forest-Trevena Ink Deal - Analyst Blog May 14 / Zacks.com | Wider-Than-Expected Loss at Anacor - Analyst Blog May 13 / Zacks.com |
| Jazz Pharma Posts Higher Y/Y Earnings - Analyst Blog May 14 / Zacks.com | Pacira Reports Wider Loss - Analyst Blog May 10 / Zacks.com |
| Previous close | 0.91 |
| Today’s open | 0.92 |
| Day’s range | 0.84 - 0.93 |
| Volume | 441,186 |
| Average volume (3 months) | 748,597 |
| Market cap | $37.9M |
| Dividend yield | -- |
| Earnings growth (last year) | +51.72% |
| Earnings growth (this year) | -107.14% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.59 |
| Today’s change | Today’s % change | |
|---|---|---|
| --BioZone Pharmaceutic... | 0.00 | 0.00% |
| BLRXBioline RX Ltd | -0.08 | -4.57% |
| IPCIIntellipharmaceutics... | +0.01 | +0.55% |
| ANTBAntriaBio Inc | -0.02 | -1.98% |
| Last reporting date | May 21, 2013 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$4.1M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Patrick J. McEnany |
Chief Operating & Scientific Officer Steven R. Miller, PhD |
Corporate headquarters Coral Gables, Florida |
.
